Inflammation in obesity, diabetes, and related disorders

TV Rohm, DT Meier, JM Olefsky, MY Donath - Immunity, 2022 - cell.com
Obesity leads to chronic, systemic inflammation and can lead to insulin resistance (IR), β-cell
dysfunction, and ultimately type 2 diabetes (T2D). This chronic inflammatory state …

Myocardial ischemia-reperfusion injury and the influence of inflammation

M Algoet, S Janssens, U Himmelreich, W Gsell… - Trends in cardiovascular …, 2023 - Elsevier
Acute myocardial infarction is caused by a sudden coronary artery occlusion and leads to
ischemia in the corresponding myocardial territory which generally results in myocardial …

Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease

A Abbate, S Toldo, C Marchetti, J Kron… - Circulation …, 2020 - Am Heart Assoc
The intracellular sensing protein termed NLRP3 (for NACHT, LRR, and PYD domains-
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …

Targeting innate immune mediators in type 1 and type 2 diabetes

MY Donath, CA Dinarello… - Nature Reviews …, 2019 - nature.com
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …

Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease

L Liberale, F Montecucco, JC Tardif… - European heart …, 2020 - academic.oup.com
The ongoing worldwide increase in life expectancy portends a rising prevalence of age-
related cardiovascular (CV) diseases in the coming decades that demands a deeper …

Management of myocarditis-related cardiomyopathy in adults

C Tschöpe, LT Cooper, G Torre-Amione… - Circulation …, 2019 - Am Heart Assoc
Myocarditis is generally a mild and self-limited consequence of systemic infection of
cardiotropic viruses. However, patients can develop a temporary or permanent impairment …

Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction

A Abbate, CR Trankle, LF Buckley… - Journal of the …, 2020 - Am Heart Assoc
Background ST‐segment–elevation myocardial infarction is associated with an intense
acute inflammatory response and risk of heart failure. We tested whether interleukin‐1 …

Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease

AW Aday, PM Ridker - Frontiers in cardiovascular medicine, 2019 - frontiersin.org
As biologic, epidemiologic, and clinical trial data have demonstrated, inflammation is a key
driver of atherosclerosis. Circulating biomarkers of inflammation, including high-sensitivity C …

NLRP3 inflammasome: The rising star in cardiovascular diseases

Y Zheng, L Xu, N Dong, F Li - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Cardiovascular diseases (CVDs) are the prevalent cause of mortality around the world.
Activation of inflammasome contributes to the pathological progression of cardiovascular …

Update on heart failure management and future directions

HM Choi, MS Park, JC Youn - The Korean journal of internal …, 2018 - pmc.ncbi.nlm.nih.gov
Heart failure (HF) is an important cardiovascular disease because of its increasing
prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The …